Tag #Teva Pharmaceuticals

Showing 1 to 2 of 2 results

jpost.com
🌐 75% Global Worthiness
News related image

Teva's Market Cap Falls $6 Billion Despite Positive 2024 Results

Teva Pharmaceutical Industries' market cap fell by roughly $6 billion to $18.8 billion after its 2025 profit guidance disappointed investors despite positive 2024 results that exceeded expectations, prompting CEO Richard Francis to highlight the company's growth strategy focusing on branded drugs.

Progress

52% Bias Score

Good Health and Well-being
jpost.com
🌐 75% Global Worthiness
News related image

Teva Exceeds 2024 Expectations but 2025 Outlook Disappoints

Teva Pharmaceutical Industries reported exceeding 2024 financial results with $4.2 billion in Q4 revenue and $16.5 billion in full-year revenue; however, its share price fell almost 10% due to a less optimistic 2025 outlook of $16.8-17.4 billion in revenue and $2.35-2.65 non-GAAP EPS.

Progress

36% Bias Score

Good Health and Well-being

Showing 1 to 2 of 2 results